Company Overview - Almadex Minerals Ltd. has acquired the area covering most of the historic Petaca District in northern New Mexico through staking, as part of its regional exploration program focused on copper-gold potential [1] - The company holds a large mineral portfolio consisting of projects and NSR royalties in Canada, the U.S., and Mexico, and has significant experience in porphyry lithocap exploration [6] Exploration Focus - The Petaca District has a history of mica production and contains rare earth element (REE) bearing minerals, which were occasionally recovered as by-products of mica mining [2] - Almadex's exploration program prioritizes porphyry lithocaps and epithermal precious metal systems, although REE projects are not the company's core focus [4][5] Technical Insights - The pegmatites in the Petaca District exhibit various forms and have been noted for their elevated REE concentrations, primarily reflecting the mineral samarskite [2] - A microprobe study confirmed the presence of several minerals, including Samarskite-(Y) and polycrase-(Y), indicating a high level of niobium (Nb) and yttrium (Y) in accessory minerals [3] Future Plans - The company intends to seek a joint venture partner with expertise in REE mineral systems to explore the Petaca District [4][5] - Almadex plans to advance and test its lithocap targets in 2025, leveraging its in-house exploration capacity and drilling units [6]

Core Viewpoint - Capital Power Corporation has successfully closed a private offering of US$700 million in senior notes due 2028 and US$500 million in senior notes due 2035 to fund acquisitions and future growth opportunities [1][2] Group 1: Offering Details - The offering includes US$700 million of 5.257% senior notes due 2028 and US$500 million of 6.189% senior notes due 2035, issued by Capital Power (US Holdings) Inc., a wholly-owned subsidiary [1] - The notes are guaranteed by Capital Power and its subsidiaries that guarantee the company's revolving credit facilities [1] Group 2: Use of Proceeds - The net proceeds from the offering will be used to fund a portion of the acquisition of Hummel Station, LLC, which owns a 1,124 MW natural gas facility, and Rolling Hills Generating, L.L.C., which owns a 1,023 MW combustion turbine natural gas facility [2] - If the acquisition is not completed by January 15, 2026, or any later agreed date, the proceeds will be used for a special mandatory redemption and to finance future growth opportunities, including acquisitions and capital development expenditures [2] Group 3: Company Overview - Capital Power is a growth-oriented power producer with approximately 10 GW of power generation capacity across 30 facilities in North America [10] - The company focuses on delivering reliable and affordable power while building lower-carbon power systems [10]

Core Viewpoint - Brooge Energy Limited intends to voluntarily delist its ordinary shares from the Nasdaq Capital Market and subsequently deregister with the SEC, citing the lack of an active trading market and the associated costs and regulatory burdens as key reasons for this decision [1][3]. Group 1: Delisting and Deregistration Process - The company plans to file a Form 25 with the SEC and Nasdaq around June 9, 2025, with the last day of quotation expected to be around June 19, 2025 [1]. - Following the delisting, Brooge Energy Limited will file a Form 15 with the SEC on or about June 19, 2025, to suspend its reporting obligations under the Exchange Act [2]. - The formal deregistration of the company's securities is expected to become effective 90 days after the filing of Form 15 [2]. Group 2: Reasons for Delisting - The decision for delisting and deregistration was made by the company's Board of Directors, based on a review of factors including the lack of an active trading market and the significant operating expenses related to compliance with SEC and Nasdaq requirements [3]. Group 3: Company Overview - Brooge Energy Limited is a Cayman Islands-based infrastructure provider engaged in Clean Petroleum Products, Biofuels, and Crude Oil storage services [4]. - The company operates through its subsidiary BPGIC FZE, located strategically outside the Strait of Hormuz at the Port of Fujairah in the UAE, differentiating itself with fast order processing, excellent customer service, and high accuracy blending services [4].

Company Overview - Healios K.K. is Japan's leading clinical stage biotechnology company focused on regenerative medicine using stem cells [3] - The company was established in 2011 and has been listed on the Tokyo Stock Exchange since 2015 under the TSE Growth Code 4593 [3] Product Development - Healios is developing a proprietary cell product called invimestrocel (HLCM051), which consists of multipotent adult progenitor cells (MAPCs) derived from the bone marrow of healthy adult donors [3] - The company is advancing invimestrocel for indications including ischemic stroke, acute respiratory distress syndrome (ARDS), and trauma [3] - Healios has confirmed its path to conditional approval in Japan for the use of invimestrocel for ARDS and is preparing to file for approval and commercial launch [3] Upcoming Events - Richard Kincaid, Chief Financial Officer of Healios, will present at the 2025 Jefferies Global Healthcare Conference on June 5, 2025, at 2:35 PM Eastern Standard Time [1] - A live and archived webcast of the presentation will be accessible from Jefferies' website, with a replay available for 60 days [2]

Company Overview - CVRx, Inc. is a commercial-stage medical device company focused on developing, manufacturing, and commercializing innovative neuromodulation solutions for patients with cardiovascular diseases [3] - The company's flagship product, Barostim™, is the first FDA-approved medical technology that uses neuromodulation to alleviate symptoms in heart failure patients [3] - Barostim is an implantable device that delivers electrical pulses to baroreceptors in the carotid artery, aiming to restore balance to the autonomic nervous system and reduce heart failure symptoms [3] Recent Developments - CVRx management will present at the William Blair 45 Annual Growth Stock Conference on June 4, 2025, at 10:00 am Central Time via webcast [1] - A live audio webcast of the conference presentation will be accessible on the investor relations page of the company's website [2] Regulatory Approvals - Barostim has received FDA Breakthrough Device designation and is FDA-approved for use in heart failure patients in the U.S. [3] - The device has also obtained the CE Mark for heart failure and resistant hypertension in the European Economic Area [3]

DALLAS, May 28, 2025 (GLOBE NEWSWIRE) -- Beneficient (NASDAQ: BENF) (“Beneficient,” “Ben” or the “Company”), a technology-enabled platform providing exit opportunities and primary capital solutions and related trust and custody services to holders of alternative assets through its proprietary online platform, AltAccess, announced today that the Company’s Annual Meeting of Stockholders, which had been previously adjourned to 2:00 p.m. Central Daylight Time today, May 28, 2025, has been once again adjourned t ...

SANTA CLARA, Calif., May 28, 2025 (GLOBE NEWSWIRE) -- SI-BONE, Inc. (Nasdaq: SIBN), a medical device company dedicated to solving sacropelvic disorders, today announced that the company will be participating in the upcoming 2025 Goldman Sachs 46th Global Healthcare Conference in Miami Beach, FL. Management will be hosting a fireside chat on Tuesday, June 10, 2025, at 8:20 a.m. Pacific Time/11:20 a.m. Eastern Time. Investors interested in listening to the conference call may do so by registering at this link ...

Company Overview - Gentherm is a global market leader in innovative thermal management and pneumatic comfort technologies, with a focus on automotive and medical products [4] - The company recorded annual sales of approximately $1.5 billion in 2024 and secured $2.4 billion in automotive new business awards [4] Upcoming Events - Gentherm will participate in the Baird Global Consumer, Technology & Services Conference on June 4, 2025, featuring a fireside chat with CEO Bill Presley and CFO Jon Douyard [2] - A live audio webcast of the fireside chat will be available, with a replay accessible for 90 days on Gentherm's Investor Relations website [3] - Additional conferences include the Stifel Cross Sector 1x1 Conference on June 3, 2025, and the Wells Fargo Industrials & Materials Conference on June 10, 2025 [5]

Company Overview - Nyxoah is a medical technology company focused on developing innovative solutions for Obstructive Sleep Apnea (OSA) [4] - The company's lead product is the Genio® system, which is a leadless and battery-free hypoglossal neurostimulation therapy for OSA [4] Recent Developments - Nyxoah will participate in the Jefferies Global Healthcare Conference from June 3 to June 5, 2025, in New York [2] - CEO Olivier Taelman will present on June 4, 2025, at 4:55 PM ET, with a webcast available on the company's Investor Relations website [3] - The company will also hold one-on-one meetings with institutional investors during the conference [3] Product Milestones - The Genio® system received its European CE Mark in 2019 following the successful completion of the BLAST OSA study [5] - Nyxoah has completed two successful IPOs: on Euronext Brussels in September 2020 and NASDAQ in July 2021 [5] - The company received CE mark approval for expanded therapeutic indications to treat Complete Concentric Collapse (CCC) patients, which are currently contraindicated in competitors' therapies [5] - Positive outcomes from the DREAM IDE pivotal study have also been announced [5]

Core Insights - Winnebago Industries, Inc. will participate in Baird's 2025 Global Consumer, Technology & Services Conference in New York City on June 5, 2025, at 1:25 p.m. ET, with CEO Michael Happe and VP Ray Posadas attending [1]. Company Overview - Winnebago Industries is a leading North American manufacturer of outdoor recreation products, including motorhomes, travel trailers, fifth-wheel products, and powerboats, under brands such as Winnebago, Grand Design, Chris-Craft, Newmar, and Barletta [3]. - The company is committed to sustainable innovation and vertical integration in key component areas, operating multiple facilities across Iowa, Indiana, Minnesota, and Florida [3]. - Winnebago Industries' common stock is listed on the New York Stock Exchange under the symbol WGO [3].